Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam vs phenobarbital for control of neonatal seizures
IRCT20160523028008N23Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levetiracetam and phenobarbital in neonatal seizure (2 arms), sponsored by Hamadan University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
levetiracetamphenobarbital
03
Conditions
neonatal seizure
Beyond the preview
Go deeper on IRCT20160523028008N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160523028008N23.